Immunology
Mast Cell Degranulation
IgE crosslinking → calcium influx → histamine and tryptase released in seconds
Tissue mast cells armed with IgE on FcεRI release histamine, tryptase, and leukotrienes within seconds when allergen crosslinks two adjacent IgE molecules. The molecular trigger of allergy.
- Histamine per cell~30 ng; released in <30 sec
- TriggerMultivalent allergen crosslinks ≥2 IgE-FcεRI
- High-affinity receptorFcεRI · Kd ≈ 10⁻¹⁰ M
- Tissue locationSkin, mucosa, near vessels and nerves
- Diagnostic markerSerum tryptase (baseline 5-15 ng/mL)
- Anti-IgE drugOmalizumab — clears free IgE, lowers FcεRI
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
From contact to histamine in 30 seconds
Walk through the signal step by step, because the speed is doing real clinical work:
- Allergen contacts the mast cell. A multivalent protein — peanut Ara h 1, bee venom phospholipase A2, dust-mite Der p 1 — has at least two epitopes recognizable by IgE.
- Two adjacent IgE-FcεRI complexes are crosslinked. Bringing two ITAMs within ~50 nanometers is the molecular trigger.
- Lyn kinase phosphorylates the ITAMs. Syk is recruited via its tandem SH2 domains and phosphorylates LAT, a transmembrane scaffold.
- PLCγ generates IP3 and DAG. IP3 opens IP3 receptors on the endoplasmic reticulum and dumps stored Ca²⁺; STIM1 then triggers store-operated Ca²⁺ entry through ORAI1.
- Calcium spikes ~10-fold within 5-15 seconds. Calcium and DAG activate PKC; vesicle SNAREs (VAMP-7, VAMP-8) zip granule membranes with the plasma membrane.
- Granules fuse and release. Preformed histamine, tryptase, chymase, heparin, and TNF-α dump into the extracellular space within 30 seconds.
- Lipid mediators follow. Cytosolic phospholipase A2 liberates arachidonic acid; 5-lipoxygenase makes leukotrienes C4/D4/E4; COX-1 makes prostaglandin D2 — over minutes.
- Late phase recruits eosinophils and basophils. TNF and cytokines bring inflammatory cells over hours, driving biphasic reactions.
The architecture is exquisite. The high-affinity receptor lets a few IgE molecules — even years after the initial Th2 sensitization — keep the mast cell armed and listening. The crosslinking requirement keeps random IgE binding from triggering false alarms. And the preformed granules make the response faster than transcription possibly could: from contact to vasoactive mediator in less than the time it takes to read this sentence.
Worked clinical example: peanut anaphylaxis at a birthday party
A 7-year-old known to be peanut-allergic eats a single piece of a peanut butter cookie at a friend's birthday party. Within two minutes she feels her throat tingle and her stomach cramp. Mast cells in her oral mucosa and gut have already crosslinked IgE specific to Ara h 2, the dominant peanut allergen. By minute three, the first wave of histamine has vasodilated her face — flushing, lip swelling — and bronchoconstricted her airways. By minute five she is wheezing, her blood pressure has dropped 20 mmHg, and capillary leak has begun. Her mother injects 0.15 mg of intramuscular epinephrine into the lateral thigh. Alpha-1 vasoconstriction reverses the leak within 30 seconds; beta-2 opens the bronchi; beta-1 supports cardiac output. Tryptase drawn at the emergency department 90 minutes later is 28 ng/mL against her baseline of 4 — confirming mast cell activation. She is observed for six hours, given a refill for her autoinjector and a referral for oral immunotherapy, and discharged. The chain of events from one bite to systemic collapse and back is a clinical clock that runs on mast cell biology.
Why mast cells matter clinically
- Anaphylaxis. The molecular substrate of life-threatening allergy — recognized by combining mucocutaneous + airway/circulatory signs after exposure.
- Chronic spontaneous urticaria. Daily hives from autoreactive IgE or IgG anti-FcεRI; omalizumab transformed treatment.
- Allergic asthma. Mast cell-derived leukotrienes and tryptase contribute to airway hyperreactivity.
- Mastocytosis. KIT D816V drives mast cell expansion; presents with flushing, GI cramps, anaphylaxis to bee sting.
- Drug pseudoallergy. MRGPRX2 activation by vancomycin, opioids, NMBAs mimics allergy without IgE — different management.
- Hereditary alpha-tryptasemia. TPSAB1 duplication in ~5% of population — explains otherwise unprovoked anaphylaxis and idiopathic urticaria.
- Mast cell activation syndrome. Increasingly recognized; tryptase, urine N-methylhistamine, and prostaglandin metabolites guide diagnosis.
Mast cell vs basophil
| Mast cell | Basophil | |
|---|---|---|
| Location | Tissue resident (skin, mucosa) | Circulating in blood (<1% WBC) |
| Origin | Marrow progenitor, matures in tissue under SCF | Marrow, released mature |
| FcεRI density | ~200,000-500,000 per cell | ~50,000-200,000 per cell |
| Lifespan | Months to years | Days |
| Histamine content | ~30 ng/cell | ~1 ng/cell |
| Tryptase | Abundant (diagnostic biomarker) | Minimal |
Common misconceptions
- Antihistamines treat anaphylaxis. They treat itch and hives only; only epinephrine reverses shock and airway edema.
- One IgE binding triggers release. Crosslinking of two or more is required — the safety latch of the system.
- Mast cells are only in skin. They sit at every body-environment interface and along vessels and nerves throughout the body.
- All drug allergies are IgE-mediated. Many are MRGPRX2 pseudoallergy — IgE-independent direct activation of mast cells.
- Tryptase rises within minutes. Peaks at 30 minutes to 2 hours after onset; draw at the right window to capture it.
- Steroids stop acute reaction. Effect over 4-6 hours; useful for preventing biphasic reactions, useless for the first wave.
Frequently asked questions
Why does crosslinking trigger degranulation but single IgE binding does not?
FcεRI is a tetramer (αβγγ) whose β and γ chains carry ITAM motifs. Single allergen-IgE engagement leaves receptors dispersed; the ITAMs are not in productive contact with the Lyn kinase. Crosslinking by a multivalent allergen brings two or more FcεRI complexes within nanometers — Lyn trans-phosphorylates the ITAMs, recruits Syk through its tandem SH2 domains, and the signal explodes through LAT scaffolds. The requirement for crosslinking is the safety latch: monovalent occupancy of the receptor is harmless, which is why most IgE-decorated mast cells in tissue sit quiet for years.
What is in a mast cell granule?
Each granule holds preformed bioactive cargo bound to a sulfated proteoglycan matrix (heparin in connective-tissue mast cells, chondroitin sulfate in mucosal). Cargo: histamine (~30 nanograms per cell, releasing within seconds), tryptase (the most abundant protein, ~10-35 picograms per cell), chymase, carboxypeptidase A3, heparin, TNF-α, IL-4 (some preformed). One human mast cell contains hundreds of granules. Beyond preformed mediators, mast cell activation triggers de novo synthesis of leukotrienes C4, D4, E4 from arachidonic acid via 5-lipoxygenase, prostaglandin D2 via COX, and platelet-activating factor.
How fast does histamine work and what does it do?
Granule fusion is complete within 30 seconds; histamine reaches local capillaries in under a minute. Through H1 receptors on endothelium: vasodilation (warmth, redness), increased permeability (wheal, swelling), itch via nerve C-fibers, bronchoconstriction in airway smooth muscle. Through H2 receptors: gastric acid secretion (parietal cells), positive cardiac chronotropy. Through H3: presynaptic neurotransmitter regulation. Through H4: chemotaxis of eosinophils and basophils. Plasma half-life is about 1-2 minutes — broken down by histamine N-methyltransferase and diamine oxidase. The fast clearance is why H1 antagonists work prophylactically but not in established anaphylactic shock.
What is the difference between IgE-mediated and IgE-independent degranulation?
IgE-mediated requires prior sensitization, IgE production, and FcεRI loading — clinical allergy. IgE-independent operates through MRGPRX2 (Mas-related G-protein coupled receptor X2), a basic-secretagogue receptor that detects cationic peptides and small molecules. Vancomycin (red man syndrome), neuromuscular blockers (atracurium, rocuronium), opioids (codeine, morphine), fluoroquinolones, and icatibant can trigger MRGPRX2 — clinically indistinguishable from allergy but tryptase rise is often smaller and skin testing negative. Important because a patient labeled allergic to vancomycin or opioids may simply be MRGPRX2-reactive and tolerant of dose reduction or pretreatment.
How is anaphylaxis confirmed in the lab?
Serum tryptase drawn 30 minutes to 4 hours after onset. Baseline tryptase is typically 5-15 ng/mL (reflecting ongoing mast cell turnover). Anaphylaxis is confirmed when peak tryptase exceeds 1.2× baseline + 2 ng/mL (the Valent formula). A baseline tryptase persistently above 20 ng/mL suggests mastocytosis or the hereditary alpha-tryptasemia trait (TPSAB1 duplication, ~5% of population, predisposes to severe anaphylaxis). Histamine itself rises and falls too fast to capture clinically. Skin testing and serum specific IgE establish the trigger after recovery.
What drugs target mast cell biology?
H1 antagonists (cetirizine, fexofenadine) — block histamine at end-organ receptors, useful for urticaria/itch but not for shock. H2 antagonists (famotidine) — gastric protection and some adjuvant effect in anaphylaxis. Cromolyn sodium — stabilizes the membrane, prevents granule fusion (limited oral bioavailability, used in mastocytosis GI symptoms). Leukotriene receptor antagonists (montelukast) — block downstream LTD4. Omalizumab — anti-IgE, sweeps free IgE from circulation, downregulates FcεRI density on mast cells over weeks; first-line in chronic spontaneous urticaria and severe allergic asthma. Avapritinib — KIT inhibitor for systemic mastocytosis with D816V mutation. Epinephrine remains the only acute reversal for anaphylactic shock.
Why are mast cells located where they are?
Mast cells cluster at body-environment interfaces — skin (papillary dermis), respiratory mucosa, gut lamina propria, and conjunctiva — and along blood vessels and nerves. This is a sentinel architecture: they sit at the points where pathogens, toxins, parasites, and venoms first arrive. Their original evolutionary purpose was parasite defense (worm rejection) and venom neutralization — anaphylactic mediators evict toxins and flush vessels. Allergy is the immune system mistaking pollen or peanut for a worm. Mast cell number expands dramatically in inflamed tissue and can reach pathological levels in mastocytosis.